Last reviewed · How we verify

NCT03668990

Feasability, Validty and Reliability of Inertial Sensors

Completed NA Last updated 11 December 2018
What this trial tests

NA trial testing IMUs (Xsens, MVN Studio) in Multiple Sclerosis in 18 participants. Completed in 31 May 2018.

Timeline
1 October 2017
Primary endpoint
31 May 2018
31 May 2018

Quick facts

Lead sponsorHasselt University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment18
Start date1 October 2017
Primary completion31 May 2018
Estimated completion31 May 2018
Sites2 locations across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Multiple Sclerosis or CVA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study has 3 aimes: 1. To investigate the feasibility of using IMUs (Xsens, MVN Studio) during functional tasks to assess upper limb kinematics in pwMS and stroke survivors. On the one hand, the feasibility of performing the tasks will be investigated . On the other hand, does the XSens give valuable data? 2. To investigate the discriminative validity of kinematic measurements of upper limb movements post-stroke and pwMS in comparison with gender and age-matched healthy controls 3. To investigate the test-retest reliability of the kinematic parameters collected during the different functional tasks in pwMS and stroke survivors It is a cross-sectional case-controlled observational study, with 3 different groups: 25 Persons with Multiple sclerosis, 25 stroke patients and 50 healthy controls, matched by age and gender.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03668990.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing